was trained as both a biochemist and a
physician. He's spent the last 35 years
developing and successfully treating cancer
patients suffering with some of the most
lethal forms of cancer at his clinic in Houston,
Texas. The treatment he developed involves
a gene-targeted approach using non-toxic
peptides and amino acids, known as
Antineoplastons.
After a grueling 15-year long battle, the
Texas Medical Board has officially ended its
crusade to revoke Dr. Stanislaw Burzynski's
medical license in an effort to end his use of
Antineoplastons. The Texas Medical Board's
case against him was dismissed on November
19, 2012, just in time for Thanksgiving.
After it was revealed that the FDA had
pressured the Texas medical board to revoke
Dr. Burzynski's medical license - despite the
fact that no laws were broken, and his treatment
was proven safe and effective - the obvious
question was "why?"
The answer to this has to do with money. Lots
and lots of money... See, Dr. Burzynski owns
the patent for this treatment, and should it
actually gain FDA approval, not only would it
threaten conventional chemotherapy and radiation,
it would also result in billions of dollars of cancer
research funds being funneled over to the one
single scientist who has exclusive patent rights
- Dr. Burzynski.
Dr. Burzynski received much-needed publicity
two years ago with the release of ' Burzynski:
The Movie', which will run on FKTV at 4:45PM
Pacific tonight. This documentary is about his
remarkable cancer discovery, and how he won
the largest and possibly the most convoluted
and intriguing legal battle against the Food and
Drug Administration (FDA) in American history.
Soon afterward, the Texas Medical Board suedhim again - without success.
This year, a second film detailing his continued
struggles, and victories, is scheduled to be
released. As announced in the trailer (see below),
Dr. Burzynski is now doing the unthinkable...
He is "the first and only scientist in United States
history to enter the federal drug approval process
for a proprietary cancer therapy without any
financial support from the American government,
the pharmaceutical industry, or the cancer
establishment."
0 comments:
Post a Comment